APA

Takamatsu H., Takezako N., Zheng J., Moorhead M., Carlton V. E. H., Kong K. A., Murata R., Ito S., Miyamoto T., Yokoyama K., Matsue K., Sato T., Kurokawa T., Yagi H., Terasaki Y., Ohata K., Matsumoto M., Yoshida T., Faham M. & Nakao S. (20180529). Prognostic value of sequencing-based minimal residual disease detection in patients with multiple myeloma who underwent autologous stem-cell transplantation. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

Takamatsu H, Takezako N, Zheng J, Moorhead M, Carlton V E H, Kong K A, Murata R, Ito S, Miyamoto T, Yokoyama K, Matsue K, Sato T, Kurokawa T, Yagi H, Terasaki Y, Ohata K, Matsumoto M, Yoshida T, Faham M and Nakao S. 20180529. Prognostic value of sequencing-based minimal residual disease detection in patients with multiple myeloma who underwent autologous stem-cell transplantation. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

Takamatsu H., Takezako N., Zheng J., Moorhead M., Carlton V. E. H., Kong K. A., Murata R., Ito S., Miyamoto T., Yokoyama K., Matsue K., Sato T., Kurokawa T., Yagi H., Terasaki Y., Ohata K., Matsumoto M., Yoshida T., Faham M. and Nakao S. (20180529). Prognostic value of sequencing-based minimal residual disease detection in patients with multiple myeloma who underwent autologous stem-cell transplantation. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

Takamatsu H, Takezako N, Zheng J, Moorhead M, Carlton V E H, Kong K A, Murata R, Ito S, Miyamoto T, Yokoyama K, Matsue K, Sato T, Kurokawa T, Yagi H, Terasaki Y, Ohata K, Matsumoto M, Yoshida T, Faham M and Nakao S. Prognostic value of sequencing-based minimal residual disease detection in patients with multiple myeloma who underwent autologous stem-cell transplantation. : Annals of oncology : official journal of the European Society for Medical Oncology. 20180529.